In Brief: MacroChem
This article was originally published in The Tan Sheet
MacroChem: Transdermal ibuprofen product for muscle pain will enter Phase I/II trials. The topical formulation is based on the company's Soft Enhancement Percutaneous Absorption (SEPA) technology. The Lexington, Mass.-based firm says it will study about 400 people at two sites. The study will be coordinated by Essex Labs of Verona, N.J...
You may also be interested in...
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning